The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo

BACKGROUND: Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children with poor survival. New treatment approaches are urgently needed to improve treatment efficacy in RMS patients. DMAMCL is a novel agent from Asteraceae family that has been tested in phase I clinical trials in adul...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ning, Hua, Zhongyan, Ba, Gen, Zhang, Simeng, Liu, Zhihui, Thiele, Carol J., Li, Zhijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408795/
https://www.ncbi.nlm.nih.gov/pubmed/30850026
http://dx.doi.org/10.1186/s13046-019-1107-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408795/
https://www.ncbi.nlm.nih.gov/pubmed/30850026
http://dx.doi.org/10.1186/s13046-019-1107-1

Ejemplares similares